New Drugs

Brand/Generic Company Description
Abecma
idecabtagene vicleucel
Celgene

Intravenous T-cell immunotherapy for multiple myeloma.

Abrilada
adalimumab
Pfizer

A biosimilar to Humira.

Braftovi
encorafenib
Pfizer

A kinase inhibitor for unresectable or metastatic melanoma (used with binimetinib).

Brukinsa
zanubrutinib
BeiGene

Oral Bruton tyrosine kinase inhibitor for Waldenström’s macroglobulinemia.

Dojolvi
triheptanoin
Ultragenyx

Oral medium-chain triglyceride for long-chain fatty acid oxidation disorders.

Enhertu
trastuzumab deruxtecan
AstraZeneca

A monoclonal antibody for unresectable/metastatic HER2-positive breast cancer.

Evrysdi
risdiplam
Hoffmann-La Roche

An oral agent for spinal muscular atrophy.

Foclivia
pandemic influenza vaccine
Seqirus

An H5N1 flu vaccine for influenza prevention in officially declared pandemic situations.

Gavreto
pralsetinib
Hoffmann-La Roche

An oral kinase inhibitor for advanced/metastatic non-small cell lung cancer.

Kesimpta
ofatumumab
Novartis

A monoclonal antibody for relapsing-remitting multiple sclerosis.

Ledaga
chlormethine
Recordati Rare Diseases Canada

A topical alkylating agent for mycosis fungoides-type cutaneous T-cell lymphoma.

Mektovi
binimetinib
Pfizer

A kinase inhibitor for unresectable or metastatic melanoma (used with encorafenib).

Nextstellis
estetrol/drospirenone
Searchlight Pharma

A new combined oral contraceptive.

Phesgo
pertuzumab/trastuzumab
Hoffmann-La Roche

Monoclonal antibody fixed-dose combo for early and metastatic breast cancer.

Ponvory
ponesimod
Janssen

Oral sphingosine-1-phosphate receptor 1 modulator for relapsing remitting MS.

Retevmo
selpercatinib
Loxo (US)/Lilly

Oral protein kinase inhibitor for advanced/metastatic NSCLC, thyroid cancer.

Riabni
rituximab
Amgen

A new biosimilar to Rituxan.

Sunosi
solriamfetol
Jazz Pharma

Oral dopamine/norepinenephrine reuptake inhibitor to improve wakefulness in narcolepsy/obstructive sleep apnea.

Supemtek
influenza vaccine
Sanofi Pasteur

A quadrivalent vaccine for prevention of influenza in adults.

Tecartus
brexucabtagene autoleucel
Gilead Sciences

An immunotherapy agent for relapsed or refractory mantle cell lymphoma.

Tepmetko
tepotinib
EMD Serono

An oral protein kinase inhibitor for non-small cell lung cancer.

Triferic Avnu
ferric pyrophosphate citrate
Rockwell Medical (US)/RMC Healthcare (CAN)

Intravenous iron replacement therapy to maintain hemoglobin in hemodialysis-dependent chronic kidney disease.

Trikafta
elexacaftor/tezacaftor/ ivacaftor
Vertex

An oral CFTR corrector and potentiator for cystic fibrosis.

Vistaseal
fibrin sealant (human)
Grifols (SA)/J&J Medical

A topical hemostatic to improve hemostasis during surgery.

Vyepti
eptinezumab
Lundbeck

An injectable CGRP-binding antibody for migraine prevention in adults.

Wakix
pitolisant
Endo (Ireland)/ Paladin

An oral H-3 receptor antagonist/inverse agonist for excessive daytime sleepiness/cataplexy in narcolepsy.

Brand/Generic Company Description
Arazlo
tazarotene
Bausch Health

New strength (0.045%) topical lotion for acne.

Bryhali
halobetasol
Bausch Health

New high/super-high potency 0.01% topical steroid lotion for dermatoses and plaque psoriasis.

Cequa
cyclosporine
Sun Pharma

New 0.09% ophthalmic solution for moderate/severe dry eye.

Inprosub
progesterone
IBSA (Switz)

New subcutaneous formulation for in vitro fertilization treatment.

Onureg
azacitidine
Celgene/BMSquibb

New oral formulation for maintenance therapy in adults with acute myeloid leukemia.

Vyndamax
tafamidis
Pfizer

New higher-strength (61 mg) capsule formulation for cardiomyopathy.

Vyxeos
cytarabine/ daunorubicin
Jazz Pharma

New combination antineoplastic liposomal formulation for certain types of acute myeloid leukemia.

Brand/Generic Company Description
Ruzurgi
amifampridine
Médunik Canada

No longer marketed in Canada as Notice of Compliance is invalid. Another formulation of amifampridine (Firdapse) will continue to be available.